RENE A. ECKERT

Corporate Board Profile

Tech Score: 0/100

TENAX THERAPEUTICS, INC.

Filing Date	Source Excerpt
2010-08-27	Rene A. Eckert has served as a director since October 2009. He serves on the Audit and Compliance Committee, Compensation Committee, and Corporate Governance and Nominating Committee. 2010 Director Compensation table shows total compensation of $210,440.
2011-09-06	Rene A. Eckert has served as a director since October 2009 and as Interim Chairman since August 24, 2011. Mr. Eckert was Chairman, Chief Executive Officer and a Partner at Boehme Filatex Inc. of Reidsville, NC from 1981 to 2007. He started the specialty chemical company with two partners in 1981. They formed the company into a leading North American textile chemical corporation with subsidiaries in Canada and Mexico. In 2007, the corporation was sold to Dystar, an international dyestuff company. Mr. Eckert brings to the Board extensive experience in the manufacturing, business development and strategic planning fields. His diverse qualifications benefit both the Board and the committees he serves upon. The members of the Audit and Compliance Committee are Messrs. Engle and Eckert and Dr. Blanck. Mr. Engle serves as chair of the Audit Committee. The Board of Directors has determined that Mr. Engle is an “audit committee financial expert” as defined by applicable SEC rules. The Audit Committee met six times in fiscal 2011. The members of the Corporate Governance and Nominating Committee are Messrs. Chatfield, Eckert and Engle and Dr. Blanck. Mr. Chatfield serves as chair of the Corporate Governance and Nominating Committee. The Corporate Governance and Nominating Committee met one time in fiscal 2011.

Filing Date

Source Excerpt

2010-08-27

Rene A. Eckert has served as a director since October 2009. He serves on the Audit and Compliance Committee, Compensation Committee, and Corporate Governance and Nominating Committee. 2010 Director Compensation table shows total compensation of $210,440.

2011-09-06

Rene A. Eckert has served as a director since October 2009 and as Interim Chairman since August 24, 2011. Mr. Eckert was Chairman, Chief Executive Officer and a Partner at Boehme Filatex Inc. of Reidsville, NC from 1981 to 2007. He started the specialty chemical company with two partners in 1981. They formed the company into a leading North American textile chemical corporation with subsidiaries in Canada and Mexico. In 2007, the corporation was sold to Dystar, an international dyestuff company. Mr. Eckert brings to the Board extensive experience in the manufacturing, business development and strategic planning fields. His diverse qualifications benefit both the Board and the committees he serves upon. The members of the Audit and Compliance Committee are Messrs. Engle and Eckert and Dr. Blanck. Mr. Engle serves as chair of the Audit Committee. The Board of Directors has determined that Mr. Engle is an “audit committee financial expert” as defined by applicable SEC rules. The Audit Committee met six times in fiscal 2011. The members of the Corporate Governance and Nominating Committee are Messrs. Chatfield, Eckert and Engle and Dr. Blanck. Mr. Chatfield serves as chair of the Corporate Governance and Nominating Committee. The Corporate Governance and Nominating Committee met one time in fiscal 2011.

Data sourced from SEC filings. Last updated: 2025-07-01